TGA approves combination inhaler for mild asthma

The new indication could signal another blow for SABAs

Budesonide/formoterol is now indicated for asthma of any severity, the TGA has announced, in the latest sign that as-needed reliever-preventer therapy could usurp the role of short-acting beta-agonists (SABAs).